You are here

Webinar with Prof. Sophie Molholm: "Atypical neural processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risks"

Webinar with Prof. Sophie Molholm: "Atypical neural processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risks"

Event Date: 
Wednesday, February 15, 2023
Event Location: 
Online

22q11.2 Deletion Syndrome (22q11.2DS) is a multisystemic disorder characterized by a wide range of clinical features, ranging from life-threatening to less severe conditions. One-third of individuals with the deletion live with mild to moderate intellectual disability; approximately 60% meet criteria for at least one psychiatric condition. 22q11.2DS has become an important model for several medical, developmental, and psychiatric disorders. We have been particularly interested in understanding the risk for psychosis in this population: Approximately 30% of the individuals with the deletion go on to develop schizophrenia. The characterization of cognitive and neural differences between those individuals who develop schizophrenia and those who do not, despite being at genetic risk, holds important promise in what pertains to the clarification of paths to disease and to the development of tools for early identification and intervention.

Our presenter is Prof. Sophie Molholm, Cognitive Neuroscientist at the Albert Einstein College of Medicine, with appointments in the departments of Pediatrics, Neuroscience and Psychiatry and Behavioral Sciences. She uses multimodal brain imaging, psychophysics, and standardized cognitive and clinical assessments to probe the brain processes underlying perception and cognition in neurodevelopmental and neuropsychiatric conditions such as autism and schizophrenia as well as rare genetic disorders including 22q11.2 deletion syndrome and Rett syndrome. Her research is supported by federal and foundation grants. In addition to running her lab, she serves as Co-Director of the NIH funded Rose F. Kennedy Intellectual and Developmental Research Center, and an NIH supported training grant for postdoctoral fellows engaged in research on intellectual and developmental disabilities.

Register here free of charge. We look forward to welcoming you to this webinar!

© Copyright 1999 - 2024 ANT Neuro | www.ant-neuro.com | Terms of Use | Privacy Statement | Contact | USA Customers